Rohto Pharmaceutical Co's total assets for Q1 2026 were ¥428.33B, an increase of 1.53% from the previous quarter. JP:4527 total liabilities were ¥144.18B for the fiscal quarter, a -4.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.